Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

Recall of a Single Lot of Pilocarpine Hydrochloride 5 mg Tablets
Corepharma, LLC has voluntarily recalled a single lot of PILOCARPINE 5 mg tablets made by Sandoz (product number NDC 0781-5100-01). PILOCARPINE is commonly used to treat dry mouth caused by radiotherapy in people with head and neck cancer and to treat dry mouth in people with Sjogren's syndrome. Lot number 100535 (Exp: Mar 2011) is being recalled because some tablets may be the wrong weight and thickness. This recall alert only applies to this single lot of PILOCARPINE 5 mg tablets may by Sandoz. No other tablets and no pilocarpine eye products are involved in this recall. For more information, please visit: http://www.fda.gov/Safety/Recalls/EnforcementReports/ucm200755.htm
Learn More

Recall of Two Lots of PREMPRO 0.3 mg/1.5 mg EZ-DIAL Dispensers
Wyeth Ayerst Laboratories has voluntarily recalled three lots of PREMPRO (conjugated estrogens/medroxyprogesterone acetate tablets) 0.3 mg/1.5 mg EZ-DIAL Dispensers. PREMPRO is commonly used as hormone replace therapy in postmenopausal women. The following lot numbers are being recalled because they failed tests that measured their ability to dissolve: Lot C83323 (EXP March 2010) Lot D82196 (EXP December 2010) For more information, please visit: http://www.fda.gov/Safety/Recalls/EnforcementReports/ucm200755.htm
Learn More

Date Published Title Drug Source
2010-02-19 Recall of a Single Lot of Pilocarpine Hydrochloride 5 mg Tablets Pilocarpine FDA
2010-02-19 Recall of Two Lots of PREMPRO 0.3 mg/1.5 mg EZ-DIAL Dispensers Estrogens Conjugated with Medroxyprogesterone FDA
2010-02-23 Ongoing Review of AVANDIA (ROSIGLITAZONE) and Cardiovascular Safety Rosiglitazone FDA
2010-02-23 The FDA Is Reviewing A Possible Safety Concern for HIV Drug Combination of INVIRASE with NORVIR Saquinavir FDA
2010-03-01 LifeScan Recalls Eight Lots of OneTouch SureStep Test Strips Due To Falsely Low Readings Insulin Manufacturer
2010-03-01 Updated "Mifeprex Question and Answers" on FDA Website Mifepristone FDA
2010-03-02 Wyeth Recalls Several Lots of Effexor XR 37.5 mg, 75 mg, and 150 mg Capsules Venlafaxine FDA
2010-03-05 FDA Approves Name Change for Heartburn Drug Kapidex Dexlansoprazole FDA
2010-03-11 Black Box Warning for WinRho SDF Warns About Potentially Life Threatening Reaction WinRho SDF Manufacturer
2010-03-11 FDA Publishes Results of Ongoing Safety Review of Oral Bisphosphonates and Femur Fractures Alendronate FDA
2010-03-12 FDA Adds Boxed Warning to Plavix (Clopidogrel) Clopidogrel FDA
2010-03-15 FDA Makes Statement on the ACCORD Lipid Trial Fenofibric Acid FDA
2010-03-15 FDA Makes Statement on the ACCORD Lipid Trial Fenofibrate FDA
2010-03-16 Paddock Recalls Select Lots of Compro Prochlorperazine Suppositories At Warehouse/Retail Level Prochlorperazine FDA
2010-03-16 Novartis Issues Recall Of Single Lot of Amlodipine/Benazepril Capsules at Warehouse/Retail Level FDA
2010-03-16 Cadista Has Completed Its Recall Of Terazosin 5 mg Capsules Terazosin FDA
2010-03-16 Recall of Several Brands of Diphenhydramine HCL 25 mg Capsules Diphenhydramine FDA
2010-03-17 FDA Warns Companies to Stop Producing Unapproved Nitroglycerin Nitroglycerin FDA
2010-03-19 FDA: Ongoing Safety Review of High-Dose Simvastatin (Zocor) and Increased Risk of Muscle Injury Simvastatin FDA
2010-03-23 Eli Lilly and Company Publishes Notification of Stolen Products Fluoxetine with Olanzapine Manufacturer